High Altitude Pulmonary Hypertension Clinical Trial
Official title:
Cerebral Tissue Oxygenation in Highlanders With Pulmonary Hypertension Compared to Highlanders Without Pulmonary Hypertension and Lowlanders
The purpose of the current study is to evaluate the cerebral tissue oxygenation of Kyrgyz highlanders with high altitude pulmonary hypertension (HAPH) by performing a longitudinal cohort study. To this end, the investigators will invite the same highlanders who participated in the study in 2012 to undergo follow-up examinations in 2017, in order to allow comparisons of current results with baseline data from 2012.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05264324 -
Maximal Exercise Capacity at 2500 m of High Altitude
|
N/A | |
| Completed |
NCT05107700 -
Altitude Related Adverse Health Effects (ARAHE) in Patients With Precapillary Pulmonary Hypertension During 30h Exposure to 2500m
|
N/A | |
| Completed |
NCT05089487 -
Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary Hypertension
|
N/A | |
| Completed |
NCT05131737 -
Exercise Endurance Time on the 2nd Day at 2500 m High Altitude
|
N/A | |
| Completed |
NCT05112172 -
Effect of Oxygen Therapy for Patients With Precapillary Pulmonary Hypertension Who Experience an Altitude Related Adverse Health Effect (ARAHE) During 30h Exposure to 2500m
|
N/A | |
| Completed |
NCT03165032 -
Right Ventricular Function During Exercise in Highlanders/Lowlanders
|
||
| Completed |
NCT03165656 -
Right Ventricular Function at Rest in Highlanders/Lowlanders
|
||
| Completed |
NCT03165019 -
Time Course and Prognostic Significance of Pulmonary Artery Pressure in Highlanders.
|
||
| Completed |
NCT01566565 -
The Safety Evaluation of Drug Combinations Against High Altitude Pulmonary Hypertension
|
Phase 1 | |
| Completed |
NCT01621061 -
Sleep Related Breathing Disturbances and High Altitude Pulmonary Hypertension in Kyrgyz Highlanders
|
N/A | |
| Completed |
NCT01530464 -
The Safety Evaluation of Aminophylline and Ambrisentan When Administered Orally Alone and in Combination to Healthy Volunteers
|
Phase 1 |